Project Grant R03DA061123
Award Date
6/15/25
Completion Date
5/31/27
Dollars Obligated
$153K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $2,726,432 to support a 5-year prospective study on the co-use of cannabis and prescription opioids among emerging adults (ages 18-25) in medical settings. The primary objectives are to examine the short- and long-term trajectories of opioid and cannabis co-use, as well as the contributory roles of pain experiences, psychosocial...
This $233,250 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a data analysis study at The Washington University in St. Louis. The study aims to examine the association between early cannabis use and later opioid use disorder, including the potential roles of adverse childhood experiences, genetic liability, and comorbid stimulant use. The project will leverage data from multiple substance use...
This federal Project Grant award for $173,799.00 was provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award aims to investigate the role of the endogenous opioid system in pain perception and placebo analgesia (pain relief) at the cellular and neural circuit levels in the ventrolateral periaqueductal gray (VLPAG) and ventral tegmental area (VTA) regions of the midbrain. The research will utilize advanced in vivo...
The National Institute on Drug Abuse (NIDA) awarded a $118,457 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The grant period runs from April 15, 2025 to March 31, 2026. The objective of this project is to elucidate the genetic architecture and underlying mechanisms of chronic pain in order to inform the development of novel,...
This federal Project Grant award of $146,922.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the association between general chronic pain liability and clinically recognized substance use disorders (SUDs). The key objectives are to: 1) estimate the general and condition-specific associations between chronic pain conditions and SUDs/overdoses (ODs), and 2) estimate these effects while accounting for familial...
This $668,110 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The intervention aims to increase young adults' knowledge of cannabis products, marketing, laws, and associated risks. The grant will support the refinement of the intervention content through focus groups...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a $1,980,270 observational study to assess the neurobehavioral impacts of medical cannabis use in adults aged 35-65 in Minnesota. The key objectives are to: 1) Evaluate the effects of medical cannabis compounds on cognition, behavior, and pain relief, 2) Assess the impacts on white matter microstructure, brain function, and connectivity...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,032,192 to Yale University to conduct a comprehensive study on the cell-type specific epigenomic effects of cannabis use among people living with HIV (PWH). The research aims to dissect the interaction between HIV infection and cannabis use, and identify potential druggable therapeutic targets. This will involve profiling DNA methylation...
This National Institute on Drug Abuse (NIDA) Project Grant, awarded under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a $376,078 study exploring the antecedents and consequences of cannabis use for coping purposes. The University of Colorado, Boulder is conducting this 5-year research project, which aims to: 1) experimentally test if cannabis use quantity increases when used for coping after stress induction; 2) examine if factors like social anxiety and inhibitory...
This $503,750 federal Project Grant award, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), will fund research to investigate the effects of chronic pain on alcohol consumption behavior in heavy drinkers with temporomandibular disorder (TMD) pain. The study aims to assess the impact of pain on drinking topography, or the microstructure of individual drinking bouts, both in a controlled laboratory setting using virtual...